JGL’s prescription portfolio has been expanded with an analgesic from the "Anti-inflammatory and antirheumatic products” pharmacotherapeutic group, with the brand name:
Etorikoksib JGL 60 mg film-coated tablets
Etorikoksib JGL 90 mg film-coated tablets
14x60 mg, 14x90 mg
The product is indicated in adults and adolescents over the age of 16 for alleviating symptoms of chronic and acute pain in the following approved indications: osteoarthitis, rheumatoid arthritis and ankylosing spondylitis, pain and signs of inflammation related to acute uric arthritis (gout), and shortterm treatment of pain following a dental surgery procedure. Etorikoksib JGL is included in the CIHI supplemental list of drugs.